LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 227

Search options

  1. Article ; Online: Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.

    Liu, Xiaoran / Beck, Todd / Dhana, Klodian / Tangney, Christy C / Desai, Pankaja / Krueger, Kristin / Evans, Denis A / Rajan, Kumar B

    The journal of nutrition, health & aging

    2024  Volume 28, Issue 5, Page(s) 100211

    Abstract: Background: APOE-e4 is the strongest genetic risk factor for Alzheimer's disease. However, the influence of APOE-e4 on dietary fat intake and cognition has not been investigated.: Objective: We aim to examine the association of types of dietary fat ... ...

    Abstract Background: APOE-e4 is the strongest genetic risk factor for Alzheimer's disease. However, the influence of APOE-e4 on dietary fat intake and cognition has not been investigated.
    Objective: We aim to examine the association of types of dietary fat and their association to cognitive decline among those with and without the APOE-e4 allele.
    Methods: The study included 3,360 Chicago Health and Aging Project (CHAP) participants from four Southside Chicago communities. Global cognition was assessed using a composite score of episodic memory, perceptual speed, MMSE, and diet using a 144-item food frequency questionnaire. APOE genotype was assessed by the hME Sequenom mass-array platform. Longitudinal mixed-effect regression models were used to examine the association of dietary fat and the APOE-e4 allele with cognitive decline, adjusted for age, sex, education, smoking status, and calorie intake.
    Results: The present study involved 3,360 participants with a mean age of 74 at baseline, 62% African Americans, 63% females, and a mean follow-up of 7.8 years. Among participants with the APOE-e4 risk allele, higher intakes of total and saturated fat (SFA) were associated with a faster decline in global cognition. Among individuals with the APOE-e4 risk allele, a 5% increase in calories from SFA was associated with a 21% faster decline (β = -0.0197, P = 0.0038). In contrast, a higher intake of long-chain n-3 polyunsaturated fatty acids (LC-n3 PUFA) was associated with a slower rate of decline in global cognition among APOE-e4 carriers. Specifically, for every 1% energy increment from LC-n3 PUFA, the annual rate of global cognitive decline was slower by 0.024 standardized unit (SD 0.010, P = 0.023), about 30.4% slower annual cognitive decline. Higher SFA or other types of dietary fat were not associated with cognitive decline among APOE-e4 non-carriers.
    Conclusions: Our study found a significant association between SFA and faster cognitive decline, LC-n3 PUFA and slower cognitive decline among those with the APOE-e4 allele. Our findings suggested that higher intake of SFA might contribute faster cognitive decline in combination with APOE-e4 whereas LC-n3 PUFA might compensate the adverse effects of APOE-e4. The interaction between intakes of different types of dietary fat and APOE-e4 on cognitive function warrants further research.
    Language English
    Publishing date 2024-03-19
    Publishing country France
    Document type Journal Article
    ZDB-ID 2081921-3
    ISSN 1760-4788 ; 1279-7707
    ISSN (online) 1760-4788
    ISSN 1279-7707
    DOI 10.1016/j.jnha.2024.100211
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults.

    Rajan, Kumar B / Mcaninch, Elizabeth A / Wilson, Robert S / Dhana, Anisa / Evans-Lacko, Sara / Evans, Denis A

    Neurology

    2024  Volume 102, Issue 7, Page(s) e209168

    Abstract: Background and objectives: The association of statin initiation with incident Alzheimer disease (AD) dementia and cognitive decline by the : Methods: This population-based longitudinal cohort study was conducted in 4 urban communities in Chicago, IL, ...

    Abstract Background and objectives: The association of statin initiation with incident Alzheimer disease (AD) dementia and cognitive decline by the
    Methods: This population-based longitudinal cohort study was conducted in 4 urban communities in Chicago, IL, United States, consisting of 4,807 participants. Statin initiation is based on the inspection of medications during home assessments. Clinical diagnosis for incident AD used the NINCDS-ADRDA criteria, and longitudinal measurements of global cognition consisted of episodic memory, perceptual speed, and the Mini-Mental State Examination tests.
    Results: The study participants had a mean age of 72 years, consisting of 63% female individuals and 61% non-Hispanic Black individuals. During the study period, 1,470 (31%) participants reported statin initiation. In a covariate-adjusted competing risk model, statin initiation was associated with a reduced risk of incident clinical AD [hazard ratio (HR) 0.81 (95% CI 0.70-0.94)] compared with nonusers. This association was statistically significantly lower (
    Discussion: Our findings suggest that statins might be associated with a lower risk of incident AD among individuals with the
    Classification of evidence: This study provides Class II evidence that among those aged 65 years or older, statin initiation was associated with a reduced risk of Alzheimer disease, especially in the presence of an
    MeSH term(s) Female ; Humans ; Aged ; Male ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Alzheimer Disease/epidemiology ; Alzheimer Disease/genetics ; Apolipoprotein E4/genetics ; Longitudinal Studies ; Cognition ; Cognitive Dysfunction/epidemiology ; Cognitive Dysfunction/genetics ; Genetic Predisposition to Disease/genetics
    Chemical Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Apolipoprotein E4
    Language English
    Publishing date 2024-03-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 207147-2
    ISSN 1526-632X ; 0028-3878
    ISSN (online) 1526-632X
    ISSN 0028-3878
    DOI 10.1212/WNL.0000000000209168
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Perceived Stress, Blood Biomarkers, and Cognitive Functioning in Older Adults.

    Desai, Pankaja / Ng, Ted K S / Krueger, Kristin R / Wilson, Robert S / Evans, Denis A / Rajan, Kumar B

    Psychosomatic medicine

    2024  

    Abstract: Introduction: There is a substantial gap in knowledge regarding how perceived stress may influence the relationship between serum-measured biomarkers for Alzheimer's disease and cognitive decline.: Methods: This study consists of 1,118 older adult ... ...

    Abstract Introduction: There is a substantial gap in knowledge regarding how perceived stress may influence the relationship between serum-measured biomarkers for Alzheimer's disease and cognitive decline.
    Methods: This study consists of 1,118 older adult participants from the Chicago Health and Aging Project (CHAP) (60% Black participants and 63% female participants). Linear mixed effects regression models were conducted to examine the role of perceived stress in the association between three blood biomarkers: total tau (t-tau), glial fibrillary acid protein (GFAP), and neurofilament light chain (NfL) on global cognitive decline. Stratified analysis by stress level was also conducted to evaluate the associations between each blood biomarker and baseline cognitive function and decline. All models adjusted for age, race, sex, education, time, and their interactions with time.
    Results: The interaction of stress, NfL concentration, and time was statistically significant on global cognition (β = -0.064 (SE = 0.028), p-value = 0.023) and on episodic memory (β = -0.097 (SE = 0.036), p-value = 0.007).
    Conclusions: Greater stress level worsens the association between high NfL concentration and cognitive decline. Stress management interventions may be helpful to reduce rate of cognitive decline in individuals with high concentrations of NfL.
    Language English
    Publishing date 2024-04-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3469-1
    ISSN 1534-7796 ; 0033-3174
    ISSN (online) 1534-7796
    ISSN 0033-3174
    DOI 10.1097/PSY.0000000000001317
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Neuroticism, physical activity, and cognitive functioning in a population-based cohort of older adults.

    Desai, Pankaja / Beck, Todd / Krueger, Kristin R / Wilson, Robert S / Evans, Denis A / Rajan, Kumar B

    BMC geriatrics

    2023  Volume 23, Issue 1, Page(s) 717

    Abstract: Background: Little is known about how physical activity influences the relationship between neuroticism and cognitive function and cognitive decline.: Methods: Data from the Chicago Health and Aging Project (CHAP) was utilized to conduct this study. ... ...

    Abstract Background: Little is known about how physical activity influences the relationship between neuroticism and cognitive function and cognitive decline.
    Methods: Data from the Chicago Health and Aging Project (CHAP) was utilized to conduct this study. CHAP is a population-based cohort study of chronic conditions in older adults. Participants completed in-home interviews cycles of three years from 1993-2012. Mixed effects regression models were conducted to test the associations between physical activity, neuroticism, and the interaction between neuroticism and physical activity on outcomes: global cognitive function, global cognitive decline, episodic memory, decline in episodic memory, perceptual speed, and decline in perceptual speed. Stratified mixed effects regression models by physical activity level were conducted to test the associations between neuroticism and global cognitive function and global cognitive decline.
    Results: A total of 7,685 participants were eligible for this study. Participants were 62% female and 64% African American. We found statistically significant associations for the interaction of high physical activity and neuroticism on baseline global cognitive function (β = 0.017 (SE = 0.007), p = .010) and on the interaction of neuroticism and high physical activity on baseline episodic memory (β = 0.020 (SE = .009), p = .021) and on decline in episodic memory over time (β = -0.003 (SE = .001), p = .039).
    Conclusion: Higher physical activity lessened the association between higher neuroticism and poor cognitive outcomes.
    MeSH term(s) Humans ; Female ; Aged ; Male ; Cohort Studies ; Neuroticism ; Risk Factors ; Cognitive Dysfunction/diagnosis ; Cognitive Dysfunction/epidemiology ; Cognitive Dysfunction/psychology ; Cognition ; Exercise
    Language English
    Publishing date 2023-11-06
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2059865-8
    ISSN 1471-2318 ; 1471-2318
    ISSN (online) 1471-2318
    ISSN 1471-2318
    DOI 10.1186/s12877-023-04399-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.

    Halloway, Shannon / Evans, Denis A / Desai, Pankaja / Dhana, Klodian / Beck, Todd / Rajan, Kumar B

    Journal of the American Geriatrics Society

    2023  Volume 72, Issue 1, Page(s) 149–159

    Abstract: Background: Total tau (t-tau), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) are neuronal cytoskeletal biomarkers that may indicate greater risk of poor outcomes in age-related conditions, including mortality. Health disparities ... ...

    Abstract Background: Total tau (t-tau), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) are neuronal cytoskeletal biomarkers that may indicate greater risk of poor outcomes in age-related conditions, including mortality. Health disparities experienced by some racial minority subgroups may influence biomarker expression and effects on longevity. We aimed to examine (a) associations of serum t-tau, NfL, and GFAP with overall and cardiovascular mortality and (b) differences in associations by racial background.
    Methods: Data came from 1327 older participants from the Chicago Health and Aging Project (CHAP), a longitudinal population-based study. Cox proportional hazards regression models were used to examine associations between concentrations of serum t-tau, NfL, and GFAP biomarker(s) and mortality (overall/cardiovascular mortality based on age at death). Interaction terms were used to examine differences between African-American and European-American participants. Models were adjusted for age, sex, education, the APOE-ε4 allele, body mass index, chronic health conditions, and cognitive and physical functioning.
    Results: Models showed that fivefold higher concentrations of t-tau (HR = 1.46, 95% CI: 1.27, 1.68), NfL (HR = 2.13, 95% CI: 1.76, 2.58), and GFAP (HR = 1.43, 95% CI: 1.08, 1.90) were separately associated with increased risk of overall mortality, with higher risk in African Americans in t-tau or NfL. In models with all biomarkers, NfL (HR = 2.17, 95% CI: 1.65, 2.85) was associated with risk of overall mortality, with racial differences in t-tau. Higher concentrations of t-tau (HR = 1.32, 95% CI: 1.02, 1.70), NfL (HR = 1.95, 95% CI: 1.40, 2.72), and GFAP (HR = 1.87, 95% CI: 1.18, 2.98) were separately associated with risk of cardiovascular mortality, with racial differences in t-tau, NfL, or GFAP. In combined models, NfL (HR = 1.73, 95% CI: 1.08, 2.78) was associated with cardiovascular mortality.
    Conclusions: Serum t-tau, NfL, and GFAP may be early indicators for mortality outcomes among older adults, with racial differences among associations.
    MeSH term(s) Humans ; Aged ; Glial Fibrillary Acidic Protein ; Intermediate Filaments ; Neurofilament Proteins ; Biomarkers ; Chronic Disease ; Cardiovascular Diseases
    Chemical Substances Glial Fibrillary Acidic Protein ; Neurofilament Proteins ; Biomarkers
    Language English
    Publishing date 2023-10-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.18632
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Prevalence of Alzheimer's disease dementia in the 50 US states and 3142 counties: A population estimate using the 2020 bridged-race postcensal from the National Center for Health Statistics.

    Dhana, Klodian / Beck, Todd / Desai, Pankaja / Wilson, Robert S / Evans, Denis A / Rajan, Kumar B

    Alzheimer's & dementia : the journal of the Alzheimer's Association

    2023  Volume 19, Issue 10, Page(s) 4388–4395

    Abstract: Introduction: This study estimates the prevalence and number of people living with Alzheimer's disease (AD) dementia in 50 US states and 3142 counties.: Methods: We used cognitive data from the Chicago Health and Aging Project, a population-based ... ...

    Abstract Introduction: This study estimates the prevalence and number of people living with Alzheimer's disease (AD) dementia in 50 US states and 3142 counties.
    Methods: We used cognitive data from the Chicago Health and Aging Project, a population-based study, and combined it with the National Center for Health Statistics 2020 bridged-race population estimates to determine the prevalence of AD in adults ≥65 years.
    Results: A higher prevalence of AD was estimated in the east and southeastern regions of the United States, with the highest in Maryland (12.9%), New York (12.7%), and Mississippi (12.5%). US states with the highest number of people with AD were California, Florida, and Texas. Among larger counties, those with the highest prevalence of AD were Miami-Dade County in Florida, Baltimore city in Maryland, and Bronx County in New York.
    Discussion: The state- and county-specific estimates could help public health officials develop region-specific strategies for caring for people with AD.
    MeSH term(s) Adult ; Humans ; United States/epidemiology ; Alzheimer Disease/epidemiology ; Prevalence ; National Center for Health Statistics, U.S. ; Florida ; Aging
    Language English
    Publishing date 2023-07-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2211627-8
    ISSN 1552-5279 ; 1552-5260
    ISSN (online) 1552-5279
    ISSN 1552-5260
    DOI 10.1002/alz.13081
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Temporal Patterns of Change in Physical and Cognitive Performance.

    Desai, Pankaja / Halloway, Shannon / Krueger, Kristin R / Rajan, Kumar B / Evans, Denis A

    The journals of gerontology. Series A, Biological sciences and medical sciences

    2023  Volume 79, Issue 3

    Abstract: Background: This study examined the relation between declines in physical and cognitive performance in older people.: Methods: A population-based cohort of 7 483 adults (average age 72 years) were interviewed. Physical performance was assessed with 3 ...

    Abstract Background: This study examined the relation between declines in physical and cognitive performance in older people.
    Methods: A population-based cohort of 7 483 adults (average age 72 years) were interviewed. Physical performance was assessed with 3 standardized tests and a combination of 4 cognitive tests was used to assess cognitive function. Rate of change in physical and cognitive performance was determined for each interval between interviews. In mixed effects linear regression models adjusted for age, sex, race, and study time, and change in each factor was used to predict change in the other factor. We examined time associations by using changes in the predictor measured at 1, 2, or 3 intervals before the outcome change.
    Results: Decline in cognitive function was most strongly predicted by physical decline in the same 3-year interval. The decline in cognitive function was weaker in the 1-time interval after the decline in physical function and was not significant in later intervals. When a decline in cognitive function was used to predict a decline in physical function, the results were similar. The strongest association occurred in the same time interval so that declines in cognitive and physical performance tend to occur together.
    Conclusions: Decline in cognition and physical function seem to occur together in a short timeframe. It is important to investigate the reasons for these changes that are short-term to guide the development of interventions.
    MeSH term(s) Humans ; Aged ; Cognition Disorders ; Neuropsychological Tests ; Frailty ; Cognition ; Cognitive Dysfunction
    Language English
    Publishing date 2023-12-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1223643-3
    ISSN 1758-535X ; 1079-5006
    ISSN (online) 1758-535X
    ISSN 1079-5006
    DOI 10.1093/gerona/glad274
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Depressive Symptoms, Glial Fibrillary Acid Protein Concentrations, and Cognitive Decline in a Cohort Study.

    Desai, Pankaja / Krueger, Kristin R / Mendes de Leon, Carlos / Wilson, Robert S / Evans, Denis A / Rajan, Kumar B

    The journals of gerontology. Series A, Biological sciences and medical sciences

    2023  Volume 79, Issue 2

    Abstract: Background: Little is known about how depressive symptoms and glial fibrillary acid protein (GFAP) concentrations taken together may influence cognitive functioning. Understanding this relationship may inform strategies for screening and early ... ...

    Abstract Background: Little is known about how depressive symptoms and glial fibrillary acid protein (GFAP) concentrations taken together may influence cognitive functioning. Understanding this relationship may inform strategies for screening and early intervention to decrease the rate of cognitive decline.
    Methods: This study sample includes 1 169 participants from the Chicago Health and Aging Project (CHAP), consisting of 60% Black participants and 40% White participants, and 63% female participants and 37% male participants. CHAP is a population-based cohort study of older adults with a mean age of 77 years. Linear mixed-effects regression models tested the main effects of depressive symptoms and GFAP concentrations and their interactions on baseline cognitive function and cognitive decline over time. Models included adjustments for age, race, sex, education, chronic medical conditions, body mass index, smoking status, alcohol use, and their interactions with time.
    Results: The interaction of depressive symptomology and GFAP (β = -0.105 [standard error = 0.038], p = .006) on global cognitive function was statistically significant. Participants with depressive symptoms including and above the cutoff and high log of GFAP concentrations had more cognitive decline over time, followed by participants with depressive symptoms below the cutoff and high log of GFAP concentrations, depressive symptom scores including and above the cutoff and low log of GFAP concentrations, and depressive symptom scores below the cutoff and low log of GFAP concentrations.
    Conclusions: Depressive symptoms have an additive effect on the association between the log of GFAP and baseline global cognitive function.
    MeSH term(s) Humans ; Male ; Female ; Aged ; Cohort Studies ; Depression/epidemiology ; Depression/psychology ; Glial Fibrillary Acidic Protein ; Cognitive Dysfunction/diagnosis ; Cognition
    Chemical Substances Glial Fibrillary Acidic Protein
    Language English
    Publishing date 2023-05-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1223643-3
    ISSN 1758-535X ; 1079-5006
    ISSN (online) 1758-535X
    ISSN 1079-5006
    DOI 10.1093/gerona/glad129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Serum neurofilament light chain, brain infarcts, and the risk of stroke: a prospective population-based cohort study.

    Dhana, Anisa / DeCarli, Charles / Aggarwal, Neelum T / Dhana, Klodian / Desai, Pankaja / Evans, Denis A / Rajan, Kumar B

    European journal of epidemiology

    2023  Volume 38, Issue 4, Page(s) 427–434

    Abstract: Neurofilament light chain (NfL), a neuron-specific protein, has been related to several neurodegenerative diseases. In addition, elevated levels of NfL have also been observed in patients admitted to the hospital for stroke, suggesting that NfL as a ... ...

    Abstract Neurofilament light chain (NfL), a neuron-specific protein, has been related to several neurodegenerative diseases. In addition, elevated levels of NfL have also been observed in patients admitted to the hospital for stroke, suggesting that NfL as a biomarker may extend well beyond neurodegenerative diseases. Therefore, using data from the Chicago Health and Aging Project (CHAP), a population-based cohort study, we prospectively investigated the association of serum NfL levels with incident stroke and brain infarcts. During a follow-up of 3603 person-years, 133 (16.3%) individuals developed incident stroke, including ischemic and hemorrhagic. The HR (95%CI) of incident stroke was 1.28 (95%CI 1.10-1.50) per 1 standard deviation (SD) increase of log10 NfL serum levels. Compared to participants in the first tertile of NfL (i.e., lower levels), the risk of stroke was 1.68 times higher (95%CI 1.07-2.65) in those in the second tertile and 2.35 times higher (95%CI 1.45-3.81) in those in the third tertile of NfL. NfL levels were also positively associated with brain infarcts; 1-SD in log10 NfL levels was associated with 1.32 (95%CI 1.06-1.66) higher odds of one or more brain infarcts. These results suggest that NfL may serve as a biomarker of stroke in older adults.
    MeSH term(s) Aged ; Humans ; Biomarkers ; Brain Infarction/epidemiology ; Brain Infarction/metabolism ; Cohort Studies ; Intermediate Filaments/metabolism ; Neurodegenerative Diseases/epidemiology ; Neurodegenerative Diseases/metabolism ; Prospective Studies ; Stroke/epidemiology ; Incidence
    Chemical Substances Biomarkers
    Language English
    Publishing date 2023-03-03
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 632614-6
    ISSN 1573-7284 ; 0393-2990
    ISSN (online) 1573-7284
    ISSN 0393-2990
    DOI 10.1007/s10654-023-00978-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Race and Apolipoprotein E-e4 Allele Status Differences in the Association Between Loneliness and Cognitive Decline.

    Desai, Pankaja / Krueger, Kristin R / de Leon, Carlos Mendes / Wilson, Robert S / Evans, Denis A / Rajan, Kumar B

    Psychosomatic medicine

    2023  Volume 85, Issue 3, Page(s) 231–237

    Abstract: Objective: This study aimed to examine race and apolipoprotein E-e4 allele (APOE-e4) status differences in the longitudinal associations between loneliness and cognitive decline.: Methods: The study sample is composed of participants ( N = 7696, 64% ... ...

    Abstract Objective: This study aimed to examine race and apolipoprotein E-e4 allele (APOE-e4) status differences in the longitudinal associations between loneliness and cognitive decline.
    Methods: The study sample is composed of participants ( N = 7696, 64% Black participants and 36% White participants) from the Chicago Health and Aging Project, a population-based cohort study. Mixed-effects regression models were conducted to examine the longitudinal associations between loneliness on global cognitive function and individual tests of cognitive function. Models were also stratified by race and APOE-e4.
    Results: A greater percentage of Black participants (17%) reported loneliness at baseline visit compared with White participants (12%). Black and White participants who were lonely individuals had a similar rate of decline in global cognitive function at 0.075 (95% confidence interval [CI] = -0.082 to -0.068) standard deviation unit (SDU) per year for Black participants and at 0.075 (95% CI = -0.086 to -0.063) SDU per year for White participants. Lonely participants with APOE-e4 had a higher rate of global cognitive decline at -0.102 (95% CI = -0.115 to -0.088) SDU per year than for lonely participants without APOE-e4 at -0.052 (95% CI = -0.059 to -0.045) SDU per year.
    Conclusions: The burden of loneliness and its relation to cognitive decline is higher among participants with APOE-e4 compared with those without APOE-e4. Loneliness is associated with cognitive decline in both Black and White participants.
    MeSH term(s) Humans ; Cohort Studies ; Apolipoprotein E4/genetics ; Alleles ; Loneliness ; Apolipoproteins E/genetics ; Cognitive Dysfunction/genetics
    Chemical Substances Apolipoprotein E4 ; Apolipoproteins E
    Language English
    Publishing date 2023-01-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 3469-1
    ISSN 1534-7796 ; 0033-3174
    ISSN (online) 1534-7796
    ISSN 0033-3174
    DOI 10.1097/PSY.0000000000001168
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top